Skip to content

Exploratory clinical study for Fecal Microbiota Transplantation (FMT) for the treatment of Parkinson's disease

Exploratory clinical study for Fecal Microbiota Transplantation (FMT) for the treatment of Parkinson's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027055
Enrollment
Unknown
Registered
2019-10-30
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. in line with the diagnosis of PD with constipation; 2. aged 40-75 years old; 3. before treatment, the use of a variety of treatment methods constipation no significant improvement; 4. colonoscopy without obvious organic disease; 5. understand and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Accompanied by other acute infectious diseases such as viral hepatitis, tuberculosis infection, etc.; 2. Constipation symptoms last less than 6 months; 3. Moderate or severe chronic obstructive pulmonary disease; 4. Hepatic and renal dysfunction; 5. Patients with severe hypertension and cerebrovascular accidents; 6. Patients with congestive heart failure and unstable angina; 7. Accompanied by other serious diseases that may hinder their enrollment or affect their survival, such as cancer or AIDS, anxiety, depression, mental or legal disability; 8. Doubt or indeed have a history of alcohol/drug abuse; 9. Women of childbearing age who are pregnant during the study period; 10. There are contraindications for colonoscopy, such as intestinal perforation, intestinal obstruction, etc.; 11. Other patients considered by the investigator to be unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Gut flora composition;MDS-UPDRS;Sutset of blood immune cells;Gene expression of gut mucosa;

Countries

China

Contacts

Public ContactJie Liu

Huashan Hospital, Fudan University

jieliu@fudan.edu.cn+86 18616281372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026